India Exchange Filings

Kwality Pharmaceuticals Q2 & H1 FY27 Investor Presentation

Kwality Pharmaceuticals Ltd reports Q2FY27 revenue of ₹181.2 crore and raises FY27 revenue guidance to ₹720+ crore

  • Q2 EBITDA was ₹49.8 crore (27.5% margin) and net profit ₹29.0 crore (16.0% margin); both rose 96% and 106% YoY, respectively.
  • FY27 guidance: EBITDA of ₹189–196+ crore and PAT of ₹122+ crore.
  • KPMG was appointed statutory auditor; no exceptional items were reported.

Original Filing

This is an automated summary of a public document. Always check the original before relying on it.